ICAP’s Jessica Justman, MD, senior technical director, was featured in a Nov 23 article by MedicineNet, which reported the AztraZeneca vaccine shows effectiveness. The AstraZeneca vaccine becomes the third shot to show good effectiveness, following on the heels of promising data on vaccines from Pfizer and Moderna. Justman says:
“We are in for a rough period through the end of February. It looks hard to find a way to break it.”
Read the full article in Medicine Net
Read the latest ICAP updates on COVID-19 here
A major global health organization that has been improving public health in countries around the world for over 15 years, ICAP works to transform the health of populations through innovation, science, and global collaboration. Based at Columbia University in New York City, where it is part of the Mailman School of Public Health, ICAP has projects in more than 30 countries, working side-by-side with ministries of health and local partners to confront some of the world’s toughest health challenges. Through meaningful research, tailored technical assistance, effective training and education programs, and rigorous surveillance to measure and evaluate the impact of public health interventions, ICAP aims to realize a global vision of healthy people, empowered communities, and thriving societies. Online at icap.columbia.edu
